Patent details
EP3366668 Title: PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DESEASES
Basic Information
- Publication number:
- EP3366668
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP181669938
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DESEASES
- French Title of Invention:
- PROMÉDICAMENTS DE FUMARATES ET LEUR UTILISATION POUR LE TRAITEMENT DE DIVERSES MALADIES
- German Title of Invention:
- PRODRUGS VON FUMARATEN UND DEREN VERWENDUNG IN DER BEHANDLUNG VERSCHIEDENER ERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 26/06/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 21/06/2023
- Unitary Effect Registration Date:
- 26/06/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 14/03/2014
- Grant date:
- 21/06/2023
- EP Publication Date:
- 29/08/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/06/2023
- EP B1 Publication Date:
- 21/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/03/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/06/2023
- Name:
- Alkermes Pharma Ireland Limited
- Address:
- Connaught House 1 Burlington Road, Dublin 4, Ireland (IE)
Inventor
1
- Name:
- HENCKEN, Christopher, P.
- Address:
- United States (US)
2
- Name:
- WYNN, Thomas, Andrew
- Address:
- United States (US)
3
- Name:
- ZEIDAN, Tarek, A.
- Address:
- United States (US)
4
- Name:
- DUNCAN, Scott
- Address:
- United States (US)
5
- Name:
- SANRAME, Carlos, N.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201361782445 P
- Priority Date:
- 14/03/2013
- Priority Country:
- United States (US)
2
- Priority Number:
- 201461934365 P
- Priority Date:
- 31/01/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07C 219/08; C07C 229/16; C07C 309/18; C07C 229/12; A61K 31/221; A61P 25/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202325
- Publication date:
- 21/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202328
- Publication date:
- 12/07/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202330
- Publication date:
- 26/07/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|